rxstat › Shortages › Eptifibatide

Eptifibatide shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Eptifibatide products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 4
Reports on file
17

Reports by product

Discontinued
INTEGRILIN
0.75MG · SOLUTION · MERCK CANADA INC
DIN 02240351
Discontinued
INTEGRILIN
2MG · SOLUTION · MERCK CANADA INC
DIN 02240352
Resolved
INTEGRILIN
2MG · SOLUTION · MERCK CANADA INC
DIN 02240352 · ended Mar 22, 2022 · Requirements related to complying with good manufacturing practices.
Discontinued
EPTIFIBATIDE INJECTION
TEVA CANADA LIMITED
DIN 02405083
Discontinued
EPTIFIBATIDE INJECTION
TEVA CANADA LIMITED
DIN 02367858
Resolved
EPTIFIBATIDE INJECTION
0.75MG · SOLUTION · TEVA CANADA LIMITED
DIN 02405083 · ended Mar 3, 2017 · Disruption of the manufacture of the drug.
Resolved
EPTIFIBATIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02367858 · ended Mar 3, 2017 · Disruption of the manufacture of the drug.
Resolved
INTEGRILIN
2MG · SOLUTION · MERCK CANADA INC
DIN 02240352 · ended Sep 25, 2019 · Delay in shipping of the drug.
Avoided
INTEGRILIN
2MG · SOLUTION · MERCK CANADA INC
DIN 02240352 · ended Sep 24, 2018 · Demand increase for the drug.
Resolved
INTEGRILIN
0.75MG · SOLUTION · MERCK CANADA INC
DIN 02240351 · ended Aug 16, 2018 · Demand increase for the drug.
Resolved
INTEGRILIN
0.75MG · SOLUTION · MERCK CANADA INC
DIN 02240351 · ended Jul 13, 2018 · Demand increase for the drug.
Resolved
INTEGRILIN
2MG · SOLUTION · MERCK CANADA INC
DIN 02240352 · ended Jul 3, 2018 · Demand increase for the drug.

Showing 12 of 17 reports. All reports are on file with Health Canada.

What's happening

One or more Eptifibatide products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Eptifibatide is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).

Recent changes

Common questions

When will Eptifibatide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Eptifibatide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.